2024-02-29 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 30,000 0.0241% | $151.34 | $4.54M | -0.76% | |
2022-08-15 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | 16,186 0.0132% | $230.71 | $3.73M | -12.2% | ||
2022-02-09 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 30,000 0.0247% | $150.00 | $4.5M | +27.46% | |
2020-11-25 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 30,000 0.026% | $124.89 | $3.75M | +31.65% | |
2020-02-12 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 30,000 0.0258% | $130.00 | $3.9M | +1.36% | |
2019-11-18 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 15,000 0.0133% | $91.71 | $1.38M | +40.9% | |
2019-04-15 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 30,000 0.0275% | $88.23 | $2.65M | -1.54% | |
2018-03-13 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 30,000 0.031% | $149.00 | $4.47M | -35.36% | |
2018-03-09 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 30,000 0.0291% | $129.00 | $3.87M | -29.67% | |
2017-02-01 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 50,000 0.0572% | $39.80 | $1.99M | +100.87% | |
2017-01-25 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 30,000 0.035% | $37.95 | $1.14M | +112.64% | |
2017-01-18 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 30,000 0.0343% | $37.83 | $1.13M | +107.21% | |
2015-12-04 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 60,000 0.0707% | $109.00 | $6.54M | -39.9% | |
2014-10-13 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 220,000 0.2904% | $85.00 | $18.7M | +20.46% | |
2013-01-22 | Alnylam Pharmaceuticals, Inc. ALNY | director | 9,934 0.0144% | $20.13 | $199,971 | +95.51% | ||
2012-02-21 | Alnylam Pharmaceuticals, Inc. ALNY | director | 18,604 0.0361% | $10.75 | $199,993 | +41.4% | ||
2008-07-21 | Sale | Biogen Inc. BIIB | director | 72,500 0.0132% | $35.42 | $2.57M | -27.26% | |
2008-04-08 | Sale | Biogen Inc. BIIB | director | 99,900 0.0264% | $49.95 | $4.99M | -22.7% | |
2004-05-14 | Sale | Biogen Inc. BIIB | director | 294,100 0.088% | $58.96 | $17.34M | +2% | |
2004-05-13 | Sale | Biogen Inc. BIIB | director | 65,000 0.0039% | $11.73 | $762,450 | +2.02% |